|
1 |
The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma
Jihyun An, Hyo Jeong Kang, Eunsil Yu, Han Chu Lee, Ju Hyun Shim
|
|
2 |
The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non–Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint Inhibitors
Xiaoyan Sun, Yingnan Feng, Bin Zhang, Wuhao Huang, Xiaoliang Zhao, Hua Zhang, Dongsheng Yue, Changli Wang
Cancer Res Treat.2022;54(4):1017-1029. Published online 2021 November 23
DOI: http://dx.doi.org/10.4143/crt.2021.1007
|
|
3 |
Advances in immune checkpoint inhibitors for hepatocellular carcinoma
Ji Won Han, Su-Hyung Park
J Liver Cancer.2021;21(2):139-145. Published online 2021 September 30
DOI: http://dx.doi.org/10.17998/jlc.2021.09.24
|
|
4 |
Engineering a High-Affinity PD-1 Peptide for Optimized Immune Cell–Mediated Tumor Therapy
Yilei Chen, Hongxing Huang, Yin Liu, Zhanghao Wang, Lili Wang, Quanxiao Wang, Yan Zhang, Hua Wang
Cancer Res Treat.2022;54(2):362-374. Published online 2021 August 3
DOI: http://dx.doi.org/10.4143/crt.2021.424
|
|
5 |
Cardiac Toxicities Associated with Immune Checkpoints Inhibitors: Mechanisms, Manifestations and Management
Abdulrazzak Zarifa, Jin Wan Kim, Juan Lopez-Mattei, Nicolas Palaskas, Cezar Iliescu, Peter Y. Kim
Korean Circ J.2021;51(7):579-597. Published online 2021 May 21
DOI: http://dx.doi.org/10.4070/kcj.2021.0089
|
|
6 |
Immune Checkpoint Programmed Cell Death Protein-1 (PD-1) Expression on Bone Marrow T Cell Subsets in Patients With Plasma Cell Myeloma
Min Young Lee, Chan-Jeoung Park, Young-Uk Cho, Eunkyoung You, Seongsoo Jang, Eul Ju Seo, Jung-Hee Lee, Dok Hyun Yoon, Cheolwon Suh
|
|
7 |
Clinical Experience of Male Primary Choriocarcinoma at the Samsung Medical Center
Young Sok Ji, Se Hoon Park
Cancer Res Treat.2021;53(3):874-880. Published online 2020 December 7
DOI: http://dx.doi.org/10.4143/crt.2020.1066
|
|
8 |
Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
Sun Min Lim, Sang-We Kim, Byoung Chul Cho, Jin Hyung Kang, Myung-Ju Ahn, Dong-Wan Kim, Young-Chul Kim, Jin Soo Lee, Jong-Seok Lee, Sung Yong Lee, Keon Uk Park, Ho Jung An, Eun Kyung Cho, Tae Won Jang, Bong-Seog Kim, Joo-Hang Kim, Sung Sook Lee, Im-II Na, Seung Soo Yoo, Ki Hyeong Lee
Cancer Res Treat.2020;52(4):1112-1119. Published online 2020 May 15
DOI: http://dx.doi.org/10.4143/crt.2020.245
|
|
9 |
Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
Se Jin Im, Sang-Jun Ha
Immune Netw.2020;20(1):e2. Published online 2020 February 20
DOI: http://dx.doi.org/10.4110/in.2020.20.e2
|
|
10 |
Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw.2020;20(1):e8. Published online 2020 February 10
DOI: http://dx.doi.org/10.4110/in.2020.20.e8
|
|
11 |
Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
Se Jin Im, Sang-Jun Ha
Immune Netw.2020;20(1):e2. Published online 2020 February 4
DOI: http://dx.doi.org/10.4110/in.2020.20.e2
|
|
12 |
Peripheral Blood Immune Cell-based Biomarkers in Anti-PD-1/PD-L1 Therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw.2020;20(1):e8. Published online 2020 February 4
DOI: http://dx.doi.org/10.4110/in.2020.20.e8
|
|
13 |
PD-1: A Negative Regulator of Phagocytosis by Tumour-Associated Macrophages in Colon Cancer
Mst Shanta Islam Tultul, Young-Sang Koh
|
|
14 |
Cancer Immunotherapy Related Endocrine Adverse Effects
Hana Kim, Sun Wook Cho, Young Joo Park
|
|
15 |
Characterization and Prognostic Significance of Cutaneous Adverse Events to Anti-Programmed Cell Death-1 Therapy
Ye Jin Lee, Hak Tae Kim, Chong Hyun Won, Sung Eun Chang, Mi Woo Lee, Jee Ho Choi, Woo Jin Lee
|
|
16 |
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience
Alice Indini, Lorenza Di Guardo, Carolina Cimminiello, Domenica Lorusso, Francesco Raspagliesi, Michele Del Vecchio
|
|
17 |
Two-Round Mixed Lymphocyte Reaction for Evaluation of the Functional Activities of Anti-PD-1 and Immunomodulators
Minsuk Kwon, Young Joon Choi, Moa Sa, Su-Hyung Park, Eui-Cheol Shin
Immune Netw.2018;18(6):e45. Published online 2018 December 19
DOI: http://dx.doi.org/10.4110/in.2018.18.e45
|
|
18 |
A Case of Aggravation of Thyroid Goiter after Treatment with PD-1 Inhibitor for Breast Cancer in Patients with Underlying Hashimoto's Thyroiditis
Hana Kim, Min Joo Kim, Young Shin Song, Sun Wook Cho
|
|
19 |
Immune checkpoint inhibitors for urothelial carcinoma
Hyung Suk Kim, Ho Kyung Seo
|
|
20 |
Immune checkpoint blockade therapy for bladder cancer treatment
Jayoung Kim
|
|